Neuralink
Neuralink raises $650M Series E at $9B valuation
Quick Facts
Neuralink: Series E Funding Round
Neuralink has successfully raised $650M in Series E funding, reaching a valuation of $9B.
Company Overview
Brain-computer interface company developing implantable devices for paralysis and neurological conditions
Funding Details
The Series E round was led by Sequoia Capital, with participation from Lightspeed, Thrive Capital, ARK Investment Management.
Company Information
- Headquarters: Fremont, CA
- Founded: 2016
- Employees: 400+
- Category: HealthTech
Investment
Neuralink plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sequoia Capital: Verified investor in Series E
- Lightspeed: Verified investor in Series E
- Thrive Capital: Verified investor in Series E
- ARK Investment Management: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
